Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis

L Ouyang1, Z Shi, S Zhao

  • 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Cell Proliferation
|October 4, 2012
PubMed

Insights

Programmed cell death (PCD), including apoptosis, autophagy, and programmed necrosis, plays a crucial role in cancer. Understanding these pathways could lead to new cancer treatments targeting cell death mechanisms.

Area of Science:

  • Oncology
  • Cell Biology

Background:

  • Programmed cell death (PCD) encompasses apoptosis, autophagy, and programmed necrosis, all intracellularly regulated cell death processes.
  • These PCD pathways are integral to the fate of malignant neoplasms, with apoptosis and programmed necrosis promoting cell death, while autophagy can be pro-survival or pro-death.
  • Accumulating evidence enhances our understanding of cancer initiation and progression through these distinct cell death types.

Purpose of the Study:

  • To review the signaling pathways of apoptosis, autophagy, and programmed necrosis in cancer.
  • To discuss the regulation of apoptosis by microRNAs in the context of cancer.
  • To highlight the potential of deciphering PCD pathways for developing targeted anti-cancer therapeutics.

Main Methods:

  • Literature review of programmed cell death pathways.
  • Analysis of the interplay between apoptosis, autophagy, and programmed necrosis in cancer.
  • Examination of microRNA regulation in apoptosis related to cancer.

Main Results:

  • Apoptosis and programmed necrosis are consistently cell-lethal, whereas autophagy exhibits dual roles in cancer cell survival and death.
  • Detailed understanding of PCD pathways is crucial for cancer research.
  • MicroRNA regulation of apoptosis is a significant factor in cancer progression.

Conclusions:

  • Deciphering PCD signaling pathways offers a promising avenue for novel targeted anti-cancer therapeutic strategies.
  • Harnessing the complex interplay of apoptosis, autophagy, and programmed necrosis can lead to the discovery of new drug targets for future cancer treatment.
  • Further research into PCD mechanisms is essential for advancing cancer therapy.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...